| 查看: 570 | 回复: 5 | |||
| 【有奖交流】积极回复本帖子，参与交流，就有机会分得作者 vnyh3993 的 5 个金币 ，回帖就立即获得 1 个金币，每人有 1 次机会 | |||
[交流]
IgY-Technology英文专著在Springer出版
|
|||
|
IgY-Technology: Production and Application of Egg Yolk Antibodies: Basic Knowledge for a Successful Practice, Springer Nature Group, Switzerland 近日，IgY抗体技术专著（IgY-Technology: Production and Application of Egg Yolk Antibodies: Basic Knowledge for a Successful Practice, Springer Nature Group, Switzerland. 2021. ISBN: 978-3-030-72686-7. https://www.springer.com/gp/book/9783030726867#aboutBook）在Springer出版社出版，该书是全球范围内第一部针对IgY抗体技术的系统性英文学术专著，由张小莺教授领衔主编，联合近二十个国家的四十多位学者历时多年编撰而成。 专著链接：https://www.springer.com/gp/book/9783030726867#aboutBook 该专著共18章，系统性的回顾和总结了IgY抗体技术的发展历程、技术特点和发展前沿，涉及理论基础、技术方法学及生物医药领域的研发应用。专著覆盖了IgY技术相关的各个领域，如进化视野下的IgY分子机制、受体与转运机制、免疫技术、IgY抗体的不同提取纯化策略、储存稳定性、工业化生产、在人类和兽医领域中的应用、IgY递送策略、IgY基因工程抗体制备、转基因动物开发、IgY产品报批及产业化，技术局限与创新等。 近年来，IgY抗体技术（卵黄抗体技术）不断发展，具备了相对完备统一的技术模式；不断与现代生物学技术相结合，拓展技术自生的内涵和外延；相关产品在世界范围内不断报批问世，形成了一定的产业基础。 据悉，科学出版社将与张小莺教授团队合作，在2011年中文版的基础上，适时推出IgY抗体技术中文第二版，以供中国读者和研究人员参考、交流。 图书信息 This first edited Volume on IgY-Technology, addresses the historical and dynamic development of IgY-applications. The authors cover the biological basis and theoretical context, methodological guidance, and applications of IgY-Technology. A focus is laid on the use of IgY-antibodies for prophylactic/therapeutic purposes in human and veterinary medicine. Aside from applications, the chapters also offer an evolutionary understanding of the IgY molecule, IgY receptors and practical prerequisites to produce IgY-antibodies. Guidance is given for every step of the process. Starting with an introduction to hens as a model species and including hen husbandry, hen egg-laying capacity and total IgY outcomes. Readers will also learn about immunization techniques, the advantages and limitations of different IgY extraction methods, as well as storage stability of the final product. The last part of the volume highlights hands-on aspects of applications, such as IgY delivery strategies, new methods to produce monoclonal IgY-antibodies or production of functional IgY fragments by phage-display as well as commercial exploitation of the technology. Thus, this book is a valuable resource and guide for Scientists, Clinicians and Health Product Developers in both human and veterinary medicine. 主编信息 Prof. Dr. Xiaoying ZHANG, PhD in Pharmacology (Charité Medical University Berlin), Distinguished Professor at Shaanxi Univ. of Technology (2019-present); Senior Researcher at CBMA, Univ. of Minho, Portugal (2016-present); Professor (Adjunct) at Univ. of Guelph, Canada (2017-present); Professor at Northwest Agricultural & Forestry Univ., China (2008-2018). He has been dedicated to the development, popularisation and application of IgY Technology. Ricardo S. Vieira-Pires is an Assistant Investigator at the Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Portugal. He obtained his PhD in Structural Biology (2008) at University Joseph Fourier, Grenoble, France. He is head of the Structural Biotechnology Group that studies proteins and molecular assemblies involved in key processes of bacterial and viral infectious diseases. He is particularly interested in targeting microbial surface-exposed virulent factors using antibodies. He is head of the CNC – Avian Technological Unit that explores bird immune repertoires for antibody discovery. He is engaged with academic and industry partners promoting IgY Technology-based solutions for human and veterinary medicine. Patricia M. Morgan is an Emerita Senior Lecturer at the National University of Ireland Galway (NUI Galway). Having been awarded a PhD in Biochemistry at NUI Galway, she undertook post-doctoral research at the University of Wisconsin-Madison, USA in the areas of reproductive biology and endocrinology. She has held senior positions at NUI Galway as Dean of the College of Science and Dean of Graduate Studies. In these posts, she has championed research developments within the University particularly in the areas of Biotechnology and Innovation. She has served on various national committees promoting science and is an advocate for the public understanding of science and the promotion of inclusion and diversity in academia. Rüdiger Schade started his scientific career at the Institute of Pharmacology, Charité – Universitätsmedizin in Berlin, Germany, in 1976. Since the early 1990’s, his research has been strongly focused on the development, production and application of IgY antibodies. His contributions significantly influenced the field of IgY-technology and promoted the application of this technology worldwide, particularly in Latin-America. In acknowledgement of his research efforts, he received the FISEA prize – the International Foundation for the Substitution of Animal Experimentation, Luxemburg - in 1997. |
回复此楼» 猜你喜欢
售SCI一区T0P文章，我:8.O.5.5.1.O.5.4,科目齐全,可+急
已经有7人回复
-
282分材料专业求调剂院校
已经有22人回复
-
0857 资源与环境 285分
已经有3人回复
-
标题:捡漏预警|08工科/09农学调剂!英语要求低，过线即有机会!
已经有12人回复
-
一志愿安徽大学材料工程专硕313分，求调剂的学校
已经有8人回复
-
313求调剂
已经有4人回复
-
083000环境科学与工程调剂
已经有8人回复
-
材料调剂，307分
已经有12人回复
-
070300化学 280 一志愿太原理工 求调剂
已经有9人回复
-
一志愿北京化工大学材料与化工296分求调剂
已经有12人回复
» 本主题相关商家推荐: (我也要在这里推广)
» 抢金币啦！回帖就可以得到:
-
有机合成岗位招聘
+1/895
-
材料/化学相关专业2026级学术/专业型硕士研究生
+1/87
-
广东海洋大学滨海农业学院园艺系梁清志博士课题组接受园艺学和农艺与种业专业考生调剂
+1/79
-
arXiv 预印本求推荐
+2/44
-
湖北省属重点大学招收2026年材料、化学、物理背景硕士
+2/44
-
诚聘助理研究员 - 物理/材料/机械相关专业博士
+2/44
-
澳大利亚皇家墨尔本理工大学（RMIT）理学院 院士团队2026招收CSC博士生
+1/37
-
招博士，申请考核制，环境化学、理论计算、环境毒理/健康方向
+1/17
-
美国密苏里大学“柔性电子”课题组诚聘博士和博士后
+1/16
-
高校招聘
+1/14
-
福建农林大学绿色光电器件与储能电池团队招收2026年研究生(含调剂)
+1/12
-
博士招生-欢迎报考2026年陕西省重点科研创新团队（唐霖教授）的博士/硕士研究生！
+1/8
-
绿色催化氧化团队接收调剂研究生（社牛最好）
+1/5
-
请问为什么我的贴子自动到“已删除的主题”里而没有被发布？
+1/5
-
地理学数二英一316求调剂
+1/4
-
海南大学徐月山老师招生第二批博士名额2~3个，2026年9月份入学（高端设备开发方向）
+1/4
-
欢迎报考中山大学课题组，提供2026级硕士研究生名额
+1/2
-
五邑大学环境与化学化工学院欢迎化学、化工、材料背景考生报考
+1/2
-
温州大学招收2026年入学博士研究生（化学、材料、环境）
+1/2
-
青岛科技大学高分子学院老师招收硕士生2名
+1/1
简单回复
tzynew2楼
2021-03-10 15:57
回复
vnyh3993(金币+1): 谢谢参与
o 发自小木虫Android客户端
2021-03-10 16:44
回复
vnyh3993(金币+1): 谢谢参与
7
psylhh4楼
2021-03-13 20:33
回复
vnyh3993(金币+1): 谢谢参与
nono20095楼
2021-03-14 10:12
回复
vnyh3993(金币+1): 谢谢参与
`
2021-03-15 10:39
回复
vnyh3993(金币+1): 谢谢参与
。
